Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Accumulated Expenses: 2009-2025

Historic Accumulated Expenses for INNOVATE (VATE) over the last 10 years, with Sep 2025 value amounting to $110.1 million.

  • INNOVATE's Accumulated Expenses rose 18.01% to $110.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.1 million, marking a year-over-year increase of 18.01%. This contributed to the annual value of $109.7 million for FY2024, which is 54.94% up from last year.
  • As of Q3 2025, INNOVATE's Accumulated Expenses stood at $110.1 million, which was down 12.20% from $125.4 million recorded in Q2 2025.
  • In the past 5 years, INNOVATE's Accumulated Expenses registered a high of $125.4 million during Q2 2025, and its lowest value of $45.0 million during Q1 2023.
  • For the 3-year period, INNOVATE's Accumulated Expenses averaged around $82.9 million, with its median value being $73.3 million (2023).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 47.74% in 2023, then spiked by 111.49% in 2025.
  • Quarterly analysis of 5 years shows INNOVATE's Accumulated Expenses stood at $93.4 million in 2021, then decreased by 29.98% to $65.4 million in 2022, then climbed by 8.26% to $70.8 million in 2023, then skyrocketed by 54.94% to $109.7 million in 2024, then grew by 18.01% to $110.1 million in 2025.
  • Its Accumulated Expenses was $110.1 million in Q3 2025, compared to $125.4 million in Q2 2025 and $106.8 million in Q1 2025.